Navigation Links
Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis
Date:9/17/2007

-MPM Bio IV NVS Strategic Fund L.P. invests $10 million in Radius-

CAMBRIDGE, Mass., Sept. 17 /PRNewswire/ -- Radius Health ("Radius") announced today that it has granted Novartis (NYSE: NVS) an option to obtain an exclusive worldwide license (except Japan) to develop and commercialize all formulations of BA058, Radius' osteoporosis drug candidate. BA058 is a proprietary analog of hPTHrP (human parathyroid hormone-related protein) currently in Phase II development by Radius. In a separate but related agreement, the MPM Bio IV NVS Strategic Fund L.P. has purchased $10 million of Series C preferred stock of Radius.

In the event that Novartis exercises the option to license BA058, Novartis would assume the global clinical development, manufacturing, and marketing of BA058 and all associated costs. Radius would receive payments on the option exercise and on successful completion of certain development, regulatory, and commercial milestones. These payments together could total more than $500 million, part of which will be paid to Ipsen (Euronext: FR0010259150; IPN), from which Radius licensed BA058 in 2005. In addition, Radius would be eligible to receive royalties on product sales and has retained the option to co-commercialize BA058 in the United States. Additional terms were not disclosed.

"It was our stated intention to partner BA058 prior to commencing Phase III development, as this offers the best opportunity to maximize its value potential for Radius while expediting its development for the patients who need it," said C. Richard Lyttle, Ph.D., President and CEO of Radius. "Through this innovative option arrangement, we have put in place an early mechanism to partner BA058 with Novartis, a global l
'/>"/>

SOURCE Radius
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. State to offer $850K in high-tech training grants
2. Grants worth $800,000 help BellBrook Labs develop products
3. Venture-backed firms could become eligible for federal SBIR grants
4. Mithridion wins grants for Alzheimers research
5. NASDAQ grants Merge more time for compliance
6. Morgridge seed grants attract over 220 proposals
7. Medical College researchers win federal grants
8. NSF grants bolster integrative graduate study at UW-Madison
9. Three state businesses receive technology grants
10. SBC Foundation awards technology grants in Wisconsin
11. Visonex plans to expand with state grants, loan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Norris, TN (PRWEB) September 16, 2014 ... several new initiatives to position themselves for ... capabilities for labeling and encoding, Pharma Packaging ... adding new hardware and software and new ... on current Good Manufacturing Practices (cGMP), Pharma ...
(Date:9/16/2014)... ORLEANS , Sept. 16, 2014 In ... Austin, Texas -based cybersecurity company focused on authentication ... ONE, will support the ability to generate a OTP ... As a pioneer of user-based RFID authentication, 2FA,s ... for physical access, for many years. RFID authentication is ...
(Date:9/15/2014)... 2014   Global Science & Technology, Inc. ... and services for satellite and weather systems, was ... Services (OASIS) from the General Services Administration (GSA) ... provide the government best-value solutions for complex professional ... in Pool 4. The OASIS SB award has ...
(Date:9/15/2014)... patient has sepsis, a life-threatening condition in which bacteria ... too fast for antibiotics to help. A new device ... team at Harvard,s Wyss Institute for Biologically Inspired Engineering ... , "Even with the best current treatments, sepsis patients ... percent of the time," said Mike Super, Ph.D., Senior ...
Breaking Biology Technology:Adding Serialization Capabilities and Expanded Capacity, Pharma Packaging Solutions Is Preparing for 89th Year of Business 22FA, Inc. Announces RFID-based One-Time Password (OTP) Authentication 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 3Blood-cleansing biospleen device developed for sepsis therapy 2Blood-cleansing biospleen device developed for sepsis therapy 3Blood-cleansing biospleen device developed for sepsis therapy 4
... Enterprise level ... bank. , ... 2009 -- PacsDrive, LLC. ( www.pacsdrive.com ), a medical imaging software company, announced ... and medium sized health care providers to securely archive medical imaging in compliance with HIPAA ...
... , HUNTINGTON BEACH, California and ... diagnostics, announced today that,Palmetto GBA, California,s Part B Medicare administrator, ... Agendia,s,FDA-cleared breast cancer recurrence test, which has been reimbursed by,payors ... United States can now submit claims for the,MammaPrint test directly ...
... , ATLANTA, Dec. 1 GeoVax Labs, ... biopharmaceutical company developing human vaccines for diseases caused by HIV-1 ... support for World AIDS Day. , "Today is the 21st ... have lost their fight with the HIV/AIDS pandemic, we remain ...
Cached Biology Technology:PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6
(Date:9/16/2014)... associated with increased rates and intensity of tobacco smoking. ... relationship between schizophrenia and smoking stems, in part, from ... symptoms and cognitive impairment associated with the disease. , ... Biological Psychiatry , sheds light on this hypothesis. ... in the brain was lower in schizophrenia patients than ...
(Date:9/16/2014)... . CRG researchers ... Journal of Cell Biology describes how Topo 2 ... , At this very moment thousands of our body,s cells ... the body repairs damaged tissues and regenerates others like skin ... "mitosis", during which the cell duplicates its genetic material and ...
(Date:9/16/2014)... Valdez spilled 11 million gallons of oil into Alaska,s ... giant oil spill in the Gulf of Mexico in ... Journal of Consumer Research , news coverage of environmental ... catalyzing changes in the way fossil fuels are used. ... of these two events helped to resolve many of ...
Breaking Biology News(10 mins):Smoking and schizophrenia linked by alterations in brain nicotine signals 2Unraveling cell division 2Unraveling cell division 3Exxon Valdez 2014: Does media coverage of manmade disasters contribute to consumer complacency? 2
... A new book featuring a series of interviews ... available from the Inter-American Network of Academies of Sciences ... highlights the inclusion and empowerment of women in science ... Juan Pedro Laclette say in the book,s introduction that ...
... March 8, 2013 Dr. Eric Olson , chairman ... 2013 recipient of the March of Dimes Prize in Developmental ... the heart and other muscles. His work is credited ... could lead to novel treatments for heart disease and muscle ...
... a new method for attaching proteins to the surface ... membrane proteins. This enables time-resolved tracking of the interactions ... is accurate down to atomic resolution. The method is ... K4DD", in which scientists explore the interplay of drugs ...
Cached Biology News:New book celebrates women scientists in the Americas 2UTSW molecular biologist Olson wins March of Dimes developmental biology prize 2Specialised germanium surface as universal protein adapter 2Specialised germanium surface as universal protein adapter 3
Request Info...
Kit containing positive control DNA all parts of the HIV-1 genome, HIV-1 negative control DNA, Primers SK38, SK39, SK19...
Contains 0.2 g/L EDTA4Na in phosphate-buffered saline....
Immunochemistry 1 & 2...
Biology Products: